1 Market Overview

1.1 Product Overview and Scope of Gene Therapy-based Drug

1.2 Classification of Gene Therapy-based Drug by Type

1.2.1 Overview: Global Gene Therapy-based Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gene Therapy-based Drug Revenue Market Share by Type in 2020

1.2.3 Viral Gene Delivery System

1.2.4 Non-viral Gene Delivery System

1.3 Global Gene Therapy-based Drug Market by Application

1.3.1 Overview: Global Gene Therapy-based Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Global Gene Therapy-based Drug Market Size & Forecast

1.5 Global Gene Therapy-based Drug Market Size and Forecast by Region

1.5.1 Global Gene Therapy-based Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gene Therapy-based Drug Market Size by Region, (2016-2021)

1.5.3 North America Gene Therapy-based Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Gene Therapy-based Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Gene Therapy-based Drug Market Size and Prospect (2016-2026)

1.5.6 South America Gene Therapy-based Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Gene Therapy-based Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gene Therapy-based Drug Market Drivers

1.6.2 Gene Therapy-based Drug Market Restraints

1.6.3 Gene Therapy-based Drug Trends Analysis

2 Company Profiles

2.1 Biogen

2.1.1 Biogen Details

2.1.2 Biogen Major Business

2.1.3 Biogen Gene Therapy-based Drug Product and Solutions

2.1.4 Biogen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Biogen Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Gene Therapy-based Drug Product and Solutions

2.2.4 Novartis Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Gilead Sciences

2.3.1 Gilead Sciences Details

2.3.2 Gilead Sciences Major Business

2.3.3 Gilead Sciences Gene Therapy-based Drug Product and Solutions

2.3.4 Gilead Sciences Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Gilead Sciences Recent Developments and Future Plans

2.4 Sarepta Therapeutics

2.4.1 Sarepta Therapeutics Details

2.4.2 Sarepta Therapeutics Major Business

2.4.3 Sarepta Therapeutics Gene Therapy-based Drug Product and Solutions

2.4.4 Sarepta Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Sarepta Therapeutics Recent Developments and Future Plans

2.5 Alnylam Pharmaceuticals

2.5.1 Alnylam Pharmaceuticals Details

2.5.2 Alnylam Pharmaceuticals Major Business

2.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Solutions

2.5.4 Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans

2.6 Amgen

2.6.1 Amgen Details

2.6.2 Amgen Major Business

2.6.3 Amgen Gene Therapy-based Drug Product and Solutions

2.6.4 Amgen Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Amgen Recent Developments and Future Plans

2.7 Spark Therapeutics

2.7.1 Spark Therapeutics Details

2.7.2 Spark Therapeutics Major Business

2.7.3 Spark Therapeutics Gene Therapy-based Drug Product and Solutions

2.7.4 Spark Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Spark Therapeutics Recent Developments and Future Plans

2.8 Akcea Therapeutics

2.8.1 Akcea Therapeutics Details

2.8.2 Akcea Therapeutics Major Business

2.8.3 Akcea Therapeutics Gene Therapy-based Drug Product and Solutions

2.8.4 Akcea Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Akcea Therapeutics Recent Developments and Future Plans

2.9 bluebird bio

2.9.1 bluebird bio Details

2.9.2 bluebird bio Major Business

2.9.3 bluebird bio Gene Therapy-based Drug Product and Solutions

2.9.4 bluebird bio Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 bluebird bio Recent Developments and Future Plans

2.10 Sunway Biotech

2.10.1 Sunway Biotech Details

2.10.2 Sunway Biotech Major Business

2.10.3 Sunway Biotech Gene Therapy-based Drug Product and Solutions

2.10.4 Sunway Biotech Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sunway Biotech Recent Developments and Future Plans

2.11 SIBIONO

2.11.1 SIBIONO Details

2.11.2 SIBIONO Major Business

2.11.3 SIBIONO Gene Therapy-based Drug Product and Solutions

2.11.4 SIBIONO Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 SIBIONO Recent Developments and Future Plans

2.12 AnGes

2.12.1 AnGes Details

2.12.2 AnGes Major Business

2.12.3 AnGes Gene Therapy-based Drug Product and Solutions

2.12.4 AnGes Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 AnGes Recent Developments and Future Plans

2.13 Orchard Therapeutics

2.13.1 Orchard Therapeutics Details

2.13.2 Orchard Therapeutics Major Business

2.13.3 Orchard Therapeutics Gene Therapy-based Drug Product and Solutions

2.13.4 Orchard Therapeutics Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Orchard Therapeutics Recent Developments and Future Plans

2.14 Human Stem Cells Institute

2.14.1 Human Stem Cells Institute Details

2.14.2 Human Stem Cells Institute Major Business

2.14.3 Human Stem Cells Institute Gene Therapy-based Drug Product and Solutions

2.14.4 Human Stem Cells Institute Gene Therapy-based Drug Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gene Therapy-based Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Gene Therapy-based Drug Players Market Share

3.2.2 Top 10 Gene Therapy-based Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Gene Therapy-based Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gene Therapy-based Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Gene Therapy-based Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gene Therapy-based Drug Revenue Market Share by Application (2016-2021)

5.2 Gene Therapy-based Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Gene Therapy-based Drug Revenue by Type (2016-2026)

6.2 North America Gene Therapy-based Drug Revenue by Application (2016-2026)

6.3 North America Gene Therapy-based Drug Market Size by Country

6.3.1 North America Gene Therapy-based Drug Revenue by Country (2016-2026)

6.3.2 United States Gene Therapy-based Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Gene Therapy-based Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Gene Therapy-based Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Gene Therapy-based Drug Revenue by Type (2016-2026)

7.2 Europe Gene Therapy-based Drug Revenue by Application (2016-2026)

7.3 Europe Gene Therapy-based Drug Market Size by Country

7.3.1 Europe Gene Therapy-based Drug Revenue by Country (2016-2026)

7.3.2 Germany Gene Therapy-based Drug Market Size and Forecast (2016-2026)

7.3.3 France Gene Therapy-based Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Gene Therapy-based Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Gene Therapy-based Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Gene Therapy-based Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Gene Therapy-based Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Region

8.3.1 Asia-Pacific Gene Therapy-based Drug Revenue by Region (2016-2026)

8.3.2 China Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8.3.5 India Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Gene Therapy-based Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Gene Therapy-based Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Gene Therapy-based Drug Revenue by Type (2016-2026)

9.2 South America Gene Therapy-based Drug Revenue by Application (2016-2026)

9.3 South America Gene Therapy-based Drug Market Size by Country

9.3.1 South America Gene Therapy-based Drug Revenue by Country (2016-2026)

9.3.2 Brazil Gene Therapy-based Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Gene Therapy-based Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Gene Therapy-based Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Gene Therapy-based Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Country

10.3.1 Middle East & Africa Gene Therapy-based Drug Revenue by Country (2016-2026)

10.3.2 Turkey Gene Therapy-based Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Gene Therapy-based Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Gene Therapy-based Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gene Therapy-based Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gene Therapy-based Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gene Therapy-based Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gene Therapy-based Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gene Therapy-based Drug Revenue Market Share by Region (2021-2026)

Table 6. Biogen Corporate Information, Head Office, and Major Competitors

Table 7. Biogen Major Business

Table 8. Biogen Gene Therapy-based Drug Product and Solutions

Table 9. Biogen Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Gene Therapy-based Drug Product and Solutions

Table 13. Novartis Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 15. Gilead Sciences Major Business

Table 16. Gilead Sciences Gene Therapy-based Drug Product and Solutions

Table 17. Gilead Sciences Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors

Table 19. Sarepta Therapeutics Major Business

Table 20. Sarepta Therapeutics Gene Therapy-based Drug Product and Solutions

Table 21. Sarepta Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Alnylam Pharmaceuticals Major Business

Table 24. Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Solutions

Table 25. Alnylam Pharmaceuticals Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Amgen Corporate Information, Head Office, and Major Competitors

Table 27. Amgen Major Business

Table 28. Amgen Gene Therapy-based Drug Product and Solutions

Table 29. Amgen Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Spark Therapeutics Major Business

Table 32. Spark Therapeutics Gene Therapy-based Drug Product and Solutions

Table 33. Spark Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Akcea Therapeutics Major Business

Table 36. Akcea Therapeutics Gene Therapy-based Drug Product and Solutions

Table 37. Akcea Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. bluebird bio Corporate Information, Head Office, and Major Competitors

Table 39. bluebird bio Major Business

Table 40. bluebird bio Gene Therapy-based Drug Product and Solutions

Table 41. bluebird bio Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sunway Biotech Corporate Information, Head Office, and Major Competitors

Table 43. Sunway Biotech Major Business

Table 44. Sunway Biotech Gene Therapy-based Drug Product and Solutions

Table 45. Sunway Biotech Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. SIBIONO Corporate Information, Head Office, and Major Competitors

Table 47. SIBIONO Major Business

Table 48. SIBIONO Gene Therapy-based Drug Product and Solutions

Table 49. SIBIONO Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. AnGes Corporate Information, Head Office, and Major Competitors

Table 51. AnGes Major Business

Table 52. AnGes Gene Therapy-based Drug Product and Solutions

Table 53. AnGes Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors

Table 55. Orchard Therapeutics Major Business

Table 56. Orchard Therapeutics Gene Therapy-based Drug Product and Solutions

Table 57. Orchard Therapeutics Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors

Table 59. Human Stem Cells Institute Major Business

Table 60. Human Stem Cells Institute Gene Therapy-based Drug Product and Solutions

Table 61. Human Stem Cells Institute Gene Therapy-based Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Gene Therapy-based Drug Revenue (USD Million) by Players (2019-2021)

Table 63. Global Gene Therapy-based Drug Revenue Share by Players (2019-2021)

Table 64. Breakdown of Gene Therapy-based Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Gene Therapy-based Drug Players Head Office, Products and Services Provided

Table 66. Gene Therapy-based Drug Mergers & Acquisitions in the Past Five Years

Table 67. Gene Therapy-based Drug New Entrants and Expansion Plans

Table 68. Global Gene Therapy-based Drug Revenue (USD Million) by Type (2016-2021)

Table 69. Global Gene Therapy-based Drug Revenue Share by Type (2016-2021)

Table 70. Global Gene Therapy-based Drug Revenue Forecast by Type (2021-2026)

Table 71. Global Gene Therapy-based Drug Revenue by Application (2016-2021)

Table 72. Global Gene Therapy-based Drug Revenue Forecast by Application (2021-2026)

Table 73. North America Gene Therapy-based Drug Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Gene Therapy-based Drug Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Gene Therapy-based Drug Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Gene Therapy-based Drug Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Gene Therapy-based Drug Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Gene Therapy-based Drug Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Gene Therapy-based Drug Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Gene Therapy-based Drug Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Gene Therapy-based Drug Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Gene Therapy-based Drug Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Gene Therapy-based Drug Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Gene Therapy-based Drug Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Gene Therapy-based Drug Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Gene Therapy-based Drug Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Gene Therapy-based Drug Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Gene Therapy-based Drug Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Gene Therapy-based Drug Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Gene Therapy-based Drug Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Gene Therapy-based Drug Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Gene Therapy-based Drug Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Gene Therapy-based Drug Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Gene Therapy-based Drug Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Gene Therapy-based Drug Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Gene Therapy-based Drug Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Gene Therapy-based Drug Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Gene Therapy-based Drug Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Gene Therapy-based Drug Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Gene Therapy-based Drug Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Gene Therapy-based Drug Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Gene Therapy-based Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Gene Therapy-based Drug Picture

Figure 2. Global Gene Therapy-based Drug Revenue Market Share by Type in 2020

Figure 3. Viral Gene Delivery System

Figure 4. Non-viral Gene Delivery System

Figure 5. Gene Therapy-based Drug Revenue Market Share by Application in 2020

Figure 6. Neurological Diseases Picture

Figure 7. Cancer Picture

Figure 8. Other Picture

Figure 9. Global Gene Therapy-based Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Gene Therapy-based Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Gene Therapy-based Drug Revenue Market Share by Region (2016-2026)

Figure 12. Global Gene Therapy-based Drug Revenue Market Share by Region in 2020

Figure 13. North America Gene Therapy-based Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Gene Therapy-based Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Gene Therapy-based Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Gene Therapy-based Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Gene Therapy-based Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Gene Therapy-based Drug Market Drivers

Figure 19. Gene Therapy-based Drug Market Restraints

Figure 20. Gene Therapy-based Drug Market Trends

Figure 21. Biogen Recent Developments and Future Plans

Figure 22. Novartis Recent Developments and Future Plans

Figure 23. Gilead Sciences Recent Developments and Future Plans

Figure 24. Sarepta Therapeutics Recent Developments and Future Plans

Figure 25. Alnylam Pharmaceuticals Recent Developments and Future Plans

Figure 26. Amgen Recent Developments and Future Plans

Figure 27. Spark Therapeutics Recent Developments and Future Plans

Figure 28. Akcea Therapeutics Recent Developments and Future Plans

Figure 29. bluebird bio Recent Developments and Future Plans

Figure 30. Sunway Biotech Recent Developments and Future Plans

Figure 31. SIBIONO Recent Developments and Future Plans

Figure 32. AnGes Recent Developments and Future Plans

Figure 33. Orchard Therapeutics Recent Developments and Future Plans

Figure 34. Human Stem Cells Institute Recent Developments and Future Plans

Figure 35. Global Gene Therapy-based Drug Revenue Share by Players in 2020

Figure 36. Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Gene Therapy-based Drug Revenue Market Share in 2020

Figure 38. Global Top 10 Players Gene Therapy-based Drug Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Gene Therapy-based Drug Revenue Share by Type in 2020

Figure 41. Global Gene Therapy-based Drug Market Share Forecast by Type (2021-2026)

Figure 42. Global Gene Therapy-based Drug Revenue Share by Application in 2020

Figure 43. Global Gene Therapy-based Drug Market Share Forecast by Application (2021-2026)

Figure 44. North America Gene Therapy-based Drug Sales Market Share by Type (2016-2026)

Figure 45. North America Gene Therapy-based Drug Sales Market Share by Application (2016-2026)

Figure 46. North America Gene Therapy-based Drug Revenue Market Share by Country (2016-2026)

Figure 47. United States Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Gene Therapy-based Drug Sales Market Share by Type (2016-2026)

Figure 51. Europe Gene Therapy-based Drug Sales Market Share by Application (2016-2026)

Figure 52. Europe Gene Therapy-based Drug Revenue Market Share by Country (2016-2026)

Figure 53. Germany Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Gene Therapy-based Drug Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Gene Therapy-based Drug Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Gene Therapy-based Drug Revenue Market Share by Region (2016-2026)

Figure 61. China Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Gene Therapy-based Drug Sales Market Share by Type (2016-2026)

Figure 68. South America Gene Therapy-based Drug Sales Market Share by Application (2016-2026)

Figure 69. South America Gene Therapy-based Drug Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Gene Therapy-based Drug Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Gene Therapy-based Drug Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Gene Therapy-based Drug Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Gene Therapy-based Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source